How much does a box of Axitinib targeted drug cost and analysis of out-of-pocket price after medical insurance
Axitinib is a targeted drug commonly used for the treatment of advanced renal cancer. It is currently on the market in China and is included in the scope of medical insurance reimbursement. Patients can purchase original research and imported drugs at regular domestic hospitals and pharmacies, and the price of a box is about more than 4,000 yuan. Due to the coverage of medical insurance, the actual out-of-pocket payment of patients will be significantly reduced. The specific reimbursement ratio and final cost need to be confirmed in conjunction with local medical insurance policies, which can generally significantly reduce the burden of medication.
In foreign markets, the price of axitinib varies greatly, especially the price of the original drug is generally higher than the domestic price after reimbursement by medical insurance. In order to reduce the cost of treatment, some countries and regions have launched generic drugs. Among them, the Indian and Lao versions of generic drugs are relatively cheap, with each box costing only a few hundred yuan. These generic drugs are the same as the original drugs in terms of ingredients and main efficacy, making them an economical choice for many patients.
It should be noted that although the price advantage of generic drugs is obvious, the formality of the purchasing channels is very critical. If patients choose overseas generic drugs, they should ensure that they obtain them through legal and formal channels to avoid purchasing counterfeit or inferior drugs that may affect the treatment effect and physical safety. At the same time, doctors usually recommend that patients give priority to using domestically available original drugs if conditions permit to ensure drug efficacy and safety.
Overall, the launch of axitinib in China and its entry into medical insurance has helped many patients reduce treatment costs. For patients with greater financial pressure, overseas generic drugs provide another option, but when using them, doctors’ opinions should be taken into consideration, safety and economy should be weighed, and drug purchase channels should be chosen rationally to ensure smooth treatment.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)